This book unravels the role of Point-of-Care (POC) glucose monitoring as an essential part of diabetes management. It provides the reader with an in-depth knowledge and understanding of diabetes management, including:
- theneedfor POC glucosemonitoring
- theglucosedetectiontechnologies (invasive, noninvasive and continuous) beingused in the POC devices
- theanalytical performance, characteristics, pros and cons of the POC devicesdeveloped to date
- theimportance and role of glycatedhemoglobin (HbA1c) monitoringfor diabetes management
- thevarious POC devices and analyzersforthedetermination of HbA1c.
This is the first book to provide complete up-to-date information on POC glucose detection technologies and devices for diabetic monitoring and management. It will be an important reference for healthcare professionals, biomedical engineers, researchers, economists and policy makers. This book also serves as an asset and teaching aid for professionals and researchers in diabetic monitoring and management.
- The only book to provide complete up-to-date information on POC glucose detection technologies and devices for diabetic monitoring and management
- Presents the analytical performance, advantages, limitations, and characteristic features of glucose sensing technologies and commercial POC devices.
- Discusses the emerging role of glycated hemoglobin (HbA1c), an indicator of the long-term average of blood glucose.
- Empowers diabetics, as well as general population, to take care of their health, exploring smart wearable mobile healthcare devices and smartphone-based device for POC glucose monitoring.
Preface. 1. Diabetes: A growing epidemic and the need for point-of-care testing. 2. Blood glucose monitoring. 3. Non-invasive glucose monitoring. 4. Continuous glucose monitoring. 5. Glycated hemoglobin (HbA1c) monitoring for diabetic management and therapy. 6. Diabetes management software and smart applications. 7. Performance requirements, analytical accuracy and clinical accuracy of self-monitoring of blood glucose: a clinical perspective. 8. A concluding remark. Index
Dr. Sandeep K. Vashist is the Chief Scientific Officer at Vallo Med Health Care GmbH, Germany and Adjunct Full Professor at Biomedical Engineering, Vellore Institute of Technology, India. He was the Bioanalytical Scientist at Bristol-Myers Squibb Ireland (2006-2009), Team Leader for point-of-care (POC) diabetic monitoring at National University of Singapore (2009-2012), Head of Immunodiagnostics at Hahn-Schickard, Freiburg, Germany (2012-2015). He was a Visiting Senior Scientist in POCT at Klinikum rechts der Isar der TUM, Germany and Royal Melbourne Institute of Technology, Australia. His research outputs include many successful technology transfers; several assays, IVD and POCT technologies; >100 high impact factor journal publications and ~100 conference publications, numerouspatents, several book chapters, and many invited/keynote/plenary talks. He has constantly received highly prestigious fellowships and awards for scientific research excellence and innovation. He is the Editor for more than 12 highly reputed journals (such as Sci Rep,Biochem Biophys Rep, New Horiz Transl Med, Neurol Psychiat Br, Biotech Adv, Diagnostics, Sensors, Biosensors etc.). Besides, he is the expert/reviewer/advisor/consultant for many international funding agencies, industrial and healthcare authorities/settings in thefields of assays, IVD, POCT, mobile healthcare, and diabetic monitoring and management.
Prof John H.T. Luong is the Walton Fellow and Professor associated with the Department of Chemistry of University College Cork, Ireland. He was the Professor and Division Head of Biomedical Engineering of Nanyang Technological University, Singapore. He was also a distinguished Visiting Professor at University of Zhengzhou (China), a Visiting Professor at Nanocore, National University of Singapore. He also spent over 30 years at the National Research Council Canada as the Head of Biosensor Technology and Nanobiotechnology and an Adjunct Professor with the Department of Chemical Engineering, University of Waterloo, Canada. He has received several awards for his excellent contribution in research, innovation and technology transfer. He is on the Editorial Board of several Journals and the Chief Editor of Frontiers in Biotechnology and Bioengineering- Nanobiotechnology. He has 8 patents and two successful technology transfers related to biosensor technology and nanotechnology with a total value of several million dollars. He isthe expert/reviewer/advisor/consultant for many international funding agencies and enterprises. He has published more than 320 high impact factor journal manuscripts that have resulted in more than 14000 citations.